Descubra las mejores clínicas y precios de Tratamiento con medicamentos para la esclerosis múltiple en México 2026

Most major disease-modifying therapies for multiple sclerosis are approved in Mexico by the Federal Commission for the Protection against Sanitary Risks. This includes high-efficacy infusions like ocrelizumab and natalizumab, alongside oral medications and traditional injectables, often available within two years of US approval.

• Available infusions: Ocrevus, Lemtrada, and Tysabri are fully licensed for private clinic use.
• Oral therapies: Regulatory approval covers fingolimod, teriflunomide, and dimethyl fumarate for MS management.
• Regulatory oversight: Federal Commission for the Protection against Sanitary Risks (COFEPRIS) monitors drug safety and licensing.
• Advanced protocols: Facilities also offer hematopoietic stem cell transplantation and mesenchymal stem cell therapies.

Bookimed Expert Insight: Patient volume data shows Mexico serves 750 requests annually, ranking it 6th globally for medical travel. Specialized centers like Alivia Clinica Monterrey handle 4,000 patients every year. This high volume often ensures more consistent supply chains for biological therapies compared to smaller regional centers.

Patient Consensus: Patients emphasize that private neurology care is the best gateway for securing newer therapies. They recommend searching by active ingredient names rather than US brands when visiting Mexican pharmacies.

Medical care in Mexican multiple sclerosis clinics is safe when conducted in internationally accredited hospitals or specialized infusion centers. Safety relies on choosing facilities holding CSG Accreditation or COFEPRIS certification. Top-tier private clinics in Mexico City, Monterrey, and Mexicali provide care levels comparable to US standards.

• Regulatory oversight: COFEPRIS certification is mandatory to ensure facilities meet federal medical sanitary standards.
• Safety credentials: CSG Accreditation from the General Health Council identifies clinics meeting strict quality benchmarks.
• Drug authenticity: Patients should verify medication lot numbers and expiration dates to ensure proper storage.
• Neurology expertise: High-safety clinics employ board-certified neurologists rather than general practitioners for treatment oversight.

Bookimed Expert Insight: Quality indicators for MS care often hide in the patient volume and hospital infrastructure. Alivia Clinica Monterrey serves 4,000 patients annually, demonstrating the high throughput required for clinical proficiency. Selecting a boutique hospital like Hospital de la Familia in Mexicali provides the added safety of 32 private rooms and immediate proximity to the USA border for care continuity.

Patient Consensus: Real experiences highlight that safety improves when patients verify the clinic is a formal neurology practice. Many advise demanding baseline bloodwork and scheduled MRI follow-ups to maintain a unified treatment regimen across borders.

Mexico offers a full spectrum of Disease-Modifying Therapies (DMTs) for multiple sclerosis, including oral, injectable, and infusion medications. Patients can access high-efficacy treatments like Ocrevus and Tysabri, alongside biosimilar options like Rituximab, through private clinics in Mexico City, Monterrey, and Mexicali.

• Oral medications: Fingolimod, Teriflunomide, and Dimethyl fumarate are standard options at private centers.
• Infusion therapies: High-efficacy Ocrelizumab and Natalizumab require administration by specialist neurologists in hospitals.
• Injectable biologics: Interferon beta-1a and Glatiramer acetate are widely available, including affordable generic brands.
• Biosimilar access: Rituximab is a frequent, cost-effective alternative to branded anti-CD20 therapies in Mexico.

Bookimed Expert Insight: While Ocrevus ranges from $22,000 to $35,000, many patients find Rituximab biosimilars far more accessible. Specialty infusion centers like Alivia Clinica in Monterrey and Mexico City manage high patient volumes. They often provide more reliable refrigerated storage and supply chains than general pharmacies.

Patient Consensus: Patients emphasize that securing a reliable monthly supply is more critical than finding the newest drug. Many highlight that private channels offer significantly better consistency for high-efficacy infusions compared to public health systems.

Mexico offers several high-efficacy treatments for aggressive and progressive multiple sclerosis, including hematopoietic stem cell transplantation (HSCT) and advanced monoclonal antibodies like ocrelizumab. These therapies target active inflammatory cycles to slow disability progression in patients who often face strict eligibility barriers or long waitlists elsewhere.

• Cellular therapy: Autologous HSCT reboots the immune system using the patient's own blood stem cells.
• Advanced medications: COFEPRIS-approved infusions like Ocrevus and Tysabri treat active secondary or primary progression.
• Wider eligibility: Mexican clinics often accept higher EDSS scores than typical clinical trials in the US.
• Specialized facilities: Centers like Hospital de la Familia in Mexicali provide complex neuro-critical care.

Bookimed Expert Insight: Patients seeking high-efficacy therapies like ocrelizumab can save up to 84% in Mexico compared to US costs. While outpatient clinics exist, Choosing a CSG-accredited hospital like Hospital de la Familia ensures access to full neuro-rehabilitation and emergency support during intensive infusion cycles.

Patient Consensus: Many feel that progressive MS is still treatable if active inflammation is present. Patients recommend bringing detailed MRI reports and relapse timelines to secure aggressive therapy plans quickly.

Follow-up care for multiple sclerosis treatment in Mexico uses a collaborative model. You complete initial monitoring at clinics like Hospital de la Familia or Alivia Clinica Monterrey before transitioning to a local neurologist. This hybrid approach ensures continuity through medical record exchanges and pre-arranged remote telemedicine consultations.

• In-country monitoring: Clinics provide immediate post-infusion observation to manage acute reactions.
• Record transfer: Patients receive detailed treatment summaries, dosage logs, and imaging reports.
• Local coordination: Home-based neurologists manage long-term bloodwork, infection screenings, and MRIs.
• Telemedicine support: Mexican specialists offer virtual check-ins for medication adjustments or recovery.

Bookimed Expert Insight: High-volume centers like Alivia Clinica, which serves 4,000 patients annually, often provide digital copies of lab results immediately. I recommend patients choose clinics near the border, such as those in Mexicali, to simplify future physical follow-up visits if travel becomes necessary for repeat infusions.

Patient Consensus: Success depends on building a two-doctor plan. Most patients emphasize securing a local specialist willing to review foreign medical records before traveling to ensure seamless prescription continuity and urgent care at home.

Advanced Multiple Sclerosis (MS) therapies in Mexico include Autologous Hematopoietic Stem Cell Transplantation (AHSCT), high-efficacy biological infusions like Ocrevus, and regenerative Mesenchymal Stem Cell (MSC) protocols. These interventions target neuroinflammation and immune system resetting, often providing faster access to specialized care than US or European systems.

• AHSCT protocols: Centers like Clinica Ruiz utilize a non-myeloablative method to reset the immune system.
• Biological infusions: High-efficacy medications including Ocrevus (ocrelizumab) are available for $22,000 to $35,000.
• Cellular therapies: Clinics in Tijuana and Cancun administer billion-count exosome and MSC infusions.
• Specialized monitoring: Facilities like Hospital de la Familia maintain CSG Accreditation for high-quality patient safety.

Bookimed Expert Insight: Patients often focus on stem cells, but Mexico’s real advantage is rapid access to high-efficacy infusions. While US wait times can be months, private clinics like Alivia Clinica in Monterrey serve 4,000 patients annually with minimal delays. Choosing a facility with CSG Accreditation ensures the clinic meets government-verified safety standards for these intensive protocols.

Patient Consensus: Many patients emphasize that true medical advancement in Mexico means structured care with MRI monitoring and JCV risk screening. They warn against outpatient `cell shots,` preferring centers that coordinate results with home neurologists for long-term safety.